Nephros, Inc. (NEPH)

Nephros Income Statement

Financials in millions USD. Fiscal year is January - December.

Year Ending	TTM	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Revenue	14.06	14.24	9.98	10.22	8.56	10.33
Revenue Growth (YoY)	22.14%	42.74%	-2.37%	19.34%	-17.16%	81.71%
Cost of Revenue	5.58	5.83	5.24	4.58	3.65	4.25
Gross Profit	8.48	8.41	4.73	5.63	4.91	6.08
Selling, General & Admin	8.93	8.91	7.59	7.2	6.47	6.12
Research & Development	0.85	0.87	1.26	1.5	2.76	3.09
Other Operating Expenses	0.19	0.21	0.22	0.19	0.19	0.19
Operating Expenses	9.97	10	9.07	8.89	9.42	9.4
Operating Income	-1.49	-1.59	-4.34	-3.25	-4.5	-3.31
Interest Expense / Income	0	0	0.02	0.04	0.11	0.2
Other Expense / Income	-0.05	-0.02	3.03	0.81	0.15	0.14
Pretax Income	-1.44	-1.58	-7.38	-4.11	-4.77	-3.65
Income Tax	0	0	0	0	0	-0.23
Net Income	-1.44	-1.58	-7.38	-4.11	-4.77	-3.42
Shares Outstanding (Basic)	11	10	10	10	9	8
Shares Outstanding (Diluted)	11	10	10	10	9	8
Shares Change	1.98%	0.86%	2.79%	10.35%	20.37%	10.16%
EPS (Basic)	-0.14	-0.15	-0.70	-0.39	-0.52	-0.45
EPS (Diluted)	-0.14	-0.15	-0.70	-0.39	-0.52	-0.45
Free Cash Flow	-0.2	0.75	-3.37	-1.45	-7.14	-2.29
Free Cash Flow Per Share	-0.02	0.07	-0.33	-0.14	-0.79	-0.30
Gross Margin	60.31%	59.03%	47.43%	55.13%	57.39%	58.87%
Operating Margin	-10.57%	-11.19%	-43.46%	-31.83%	-52.61%	-32.04%
Profit Margin	-10.23%	-11.06%	-74.01%	-40.20%	-55.67%	-33.09%
Free Cash Flow Margin	-1.39%	5.28%	-33.79%	-14.22%	-83.42%	-22.16%
EBITDA	-1.24	-1.36	-7.01	-3.81	-4.45	-3.25
EBITDA Margin	-8.82%	-9.54%	-70.29%	-37.33%	-51.96%	-31.45%
Depreciation & Amortization	0.2	0.21	0.35	0.25	0.21	0.2
EBIT	-1.44	-1.57	-7.36	-4.07	-4.66	-3.45
EBIT Margin	-10.21%	-11.05%	-73.80%	-39.80%	-54.39%	-33.38%

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).